Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.44 USD | +0.16% |
|
-1.47% | -13.62% |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.21 | 1.05 | 1.61 | 2.01 | 2.63 | |||||
Return on Total Capital | 2.97 | 1.41 | 2.17 | 2.76 | 3.58 | |||||
Return On Equity % | 4.19 | 1.74 | 3.59 | 4.51 | 5.72 | |||||
Return on Common Equity | 4.19 | 1.74 | 3.59 | 4.51 | 5.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 63.51 | 64.54 | 65.84 | 65.95 | 66.42 | |||||
SG&A Margin | 30.83 | 30.76 | 30.29 | 29.17 | 28.22 | |||||
EBITDA Margin % | 14.3 | 11.48 | 11.88 | 12.58 | 13.18 | |||||
EBITA Margin % | 11.44 | 9.02 | 10.17 | 11.08 | 11.89 | |||||
EBIT Margin % | 7.16 | 3.22 | 4.74 | 5.74 | 7.3 | |||||
Income From Continuing Operations Margin % | 5.76 | 2.28 | 4.53 | 5.45 | 6.86 | |||||
Net Income Margin % | 5.76 | 2.28 | 4.53 | 5.45 | 6.86 | |||||
Net Avail. For Common Margin % | 5.76 | 2.28 | 4.53 | 5.45 | 6.86 | |||||
Normalized Net Income Margin | 4.68 | 1.87 | 2.86 | 4.05 | 5.32 | |||||
Levered Free Cash Flow Margin | 12.42 | 10.02 | 17.31 | 14.71 | 15.08 | |||||
Unlevered Free Cash Flow Margin | 12.44 | 10.05 | 17.35 | 14.74 | 15.1 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.49 | 0.52 | 0.54 | 0.56 | 0.58 | |||||
Fixed Assets Turnover | 4.62 | 5.5 | 6.56 | 7.82 | 9.51 | |||||
Receivables Turnover (Average Receivables) | 6.4 | 6.34 | 6.87 | 6.88 | 7.91 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.96 | 1.06 | 0.98 | 1.1 | 1.32 | |||||
Quick Ratio | 0.78 | 0.87 | 0.82 | 0.93 | 1.15 | |||||
Operating Cash Flow to Current Liabilities | 0.3 | 0.42 | 0.44 | 0.54 | 0.5 | |||||
Days Sales Outstanding (Average Receivables) | 57.16 | 57.6 | 53.1 | 53.07 | 46.29 | |||||
Average Days Payable Outstanding | 28.97 | 28.99 | 24.86 | 28.33 | 26.33 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 9.54 | 8.59 | 7.83 | 6.81 | 5.61 | |||||
Total Debt / Total Capital | 8.71 | 7.91 | 7.26 | 6.38 | 5.31 | |||||
LT Debt/Equity | 8.52 | 7.72 | 6.98 | 5.94 | 4.83 | |||||
Long-Term Debt / Total Capital | 7.78 | 7.11 | 6.47 | 5.56 | 4.58 | |||||
Total Liabilities / Total Assets | 33.23 | 30.35 | 32.88 | 31.84 | 29.64 | |||||
EBIT / Interest Expense | 182.48 | 62.54 | 95.83 | 129.19 | 212.87 | |||||
EBITDA / Interest Expense | 414.66 | 264.91 | 272.68 | 320.12 | 427.3 | |||||
(EBITDA - Capex) / Interest Expense | 393.95 | 239.02 | 259.29 | 302.38 | 413.29 | |||||
Total Debt / EBITDA | 0.8 | 0.83 | 0.73 | 0.58 | 0.47 | |||||
Net Debt / EBITDA | -0.37 | -0.65 | -0.77 | -1.21 | -1.8 | |||||
Total Debt / (EBITDA - Capex) | 0.84 | 0.92 | 0.76 | 0.62 | 0.49 | |||||
Net Debt / (EBITDA - Capex) | -0.39 | -0.72 | -0.81 | -1.28 | -1.86 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.65 | 4.85 | 3.94 | 4.59 | 4.51 | |||||
Gross Profit, 1 Yr. Growth % | 3.51 | 4.27 | 6.04 | 4.76 | 5.25 | |||||
EBITDA, 1 Yr. Growth % | 10.29 | -23.47 | 7.55 | 10.73 | 9.5 | |||||
EBITA, 1 Yr. Growth % | 14.49 | -26.53 | 17.25 | 13.89 | 12.19 | |||||
EBIT, 1 Yr. Growth % | 17.78 | -60.72 | 53.23 | 26.64 | 32.89 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -0.74 | -58.52 | 106.86 | 25.82 | 31.51 | |||||
Net Income, 1 Yr. Growth % | -10.65 | -58.52 | 106.86 | 25.82 | 31.51 | |||||
Normalized Net Income, 1 Yr. Growth % | 1.44 | -64.81 | 58.57 | 48.38 | 37.14 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 0.34 | -59.09 | 116.67 | 27.6 | 32.31 | |||||
Accounts Receivable, 1 Yr. Growth % | 51.76 | -24.25 | 22.31 | -9.98 | -8.13 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.66 | -14.28 | -11.31 | -13.4 | -14.87 | |||||
Total Assets, 1 Yr. Growth % | 2.2 | -2.71 | 2.26 | 0.44 | 2.16 | |||||
Tangible Book Value, 1 Yr. Growth % | -81.69 | 23.43 | -34.11 | 76.99 | 70.07 | |||||
Common Equity, 1 Yr. Growth % | -1.21 | 1.48 | -1.46 | 2 | 5.46 | |||||
Cash From Operations, 1 Yr. Growth % | -45.36 | 18.15 | 20.77 | 24.97 | -9.86 | |||||
Capital Expenditures, 1 Yr. Growth % | -90.96 | 71.88 | -48.26 | 24.43 | -36.32 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 2.76 | -21.08 | 79.64 | -11.13 | 7.09 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 2.74 | -20.97 | 79.39 | -11.12 | 7.04 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | 12 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.81 | 0.51 | 4.4 | 4.26 | 4.55 | |||||
Gross Profit, 2 Yr. CAGR % | 7.08 | 5.02 | 6.29 | 5.4 | 5.01 | |||||
EBITDA, 2 Yr. CAGR % | 7.23 | -3.42 | -2.45 | 9.5 | 10.12 | |||||
EBITA, 2 Yr. CAGR % | 6.04 | -2.42 | 1.57 | 16.06 | 13.03 | |||||
EBIT, 2 Yr. CAGR % | 5.24 | -25.11 | -10.58 | 41.02 | 29.73 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.12 | -35.83 | -7.37 | 61.33 | 28.64 | |||||
Net Income, 2 Yr. CAGR % | -33.87 | -39.12 | -7.37 | 61.33 | 28.64 | |||||
Normalized Net Income, 2 Yr. CAGR % | 0.47 | -34.52 | -14.42 | 55.42 | 42.65 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 3.59 | -35.93 | -5.85 | 66.27 | 29.93 | |||||
Accounts Receivable, 2 Yr. CAGR % | 6.03 | 7.22 | -3.75 | 4.93 | -9.06 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 78.05 | -12 | -12.81 | -12.36 | -14.14 | |||||
Total Assets, 2 Yr. CAGR % | 6.4 | -0.29 | -0.26 | 1.35 | 1.3 | |||||
Tangible Book Value, 2 Yr. CAGR % | -57.3 | -52.46 | -9.82 | 7.99 | 73.5 | |||||
Common Equity, 2 Yr. CAGR % | 2.34 | 0.13 | 0 | 0.26 | 3.72 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.92 | -19.65 | 19.45 | 22.85 | 6.13 | |||||
Capital Expenditures, 2 Yr. CAGR % | -47.33 | -60.59 | -5.7 | -19.76 | -10.98 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 6.5 | -6.61 | 25.36 | 26.46 | -2.53 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.44 | -6.56 | 25.48 | 26.58 | -2.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.44 | 3.49 | 1.64 | 4.46 | 4.34 | |||||
Gross Profit, 3 Yr. CAGR % | 6.79 | 6.91 | 5.36 | 5.78 | 5.35 | |||||
EBITDA, 3 Yr. CAGR % | 12.55 | -1.08 | 0.11 | 1.76 | 9.5 | |||||
EBITA, 3 Yr. CAGR % | 14.62 | -2.41 | 3.74 | 5.52 | 14.75 | |||||
EBIT, 3 Yr. CAGR % | 23.03 | -19.49 | -4.93 | 0.42 | 38.26 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.82 | -23.88 | -5.21 | 2.59 | 50.71 | |||||
Net Income, 3 Yr. CAGR % | 12.1 | -43.39 | -8.47 | 2.59 | 50.71 | |||||
Normalized Net Income, 3 Yr. CAGR % | 21.84 | -24.93 | -12.07 | 2.81 | 49.07 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.68 | -24 | -3.83 | 4.19 | 54.08 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.64 | -5.21 | 12.03 | -5.87 | 0.38 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 83.87 | 39.55 | -11.77 | -13 | -13.2 | |||||
Total Assets, 3 Yr. CAGR % | 6.76 | 3.27 | 0.56 | -0.02 | 1.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | -39.79 | -39.17 | -47 | 12.91 | 25.64 | |||||
Common Equity, 3 Yr. CAGR % | 3.63 | 2.06 | -0.41 | 0.66 | 1.96 | |||||
Cash From Operations, 3 Yr. CAGR % | -8.42 | -0.67 | -7.96 | 21.26 | 10.8 | |||||
Capital Expenditures, 3 Yr. CAGR % | -28.83 | -21.88 | -56.84 | 3.44 | -25.71 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 2.51 | -1.37 | 16.14 | 11.78 | 19.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 2.48 | -1.36 | 16.13 | 11.85 | 19.7 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.21 | 5.97 | 4.42 | 3.8 | 2.79 | |||||
Gross Profit, 5 Yr. CAGR % | 5.39 | 7.18 | 6.59 | 6.3 | 5.22 | |||||
EBITDA, 5 Yr. CAGR % | 6.69 | 7.28 | 5.24 | 2.88 | 4 | |||||
EBITA, 5 Yr. CAGR % | 6.84 | 9.71 | 7.85 | 4.41 | 7.36 | |||||
EBIT, 5 Yr. CAGR % | 3.82 | 2.86 | 6.1 | 0.26 | 7.66 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.33 | 4.06 | 6.47 | 2.8 | 7.1 | |||||
Net Income, 5 Yr. CAGR % | 10.33 | 9.25 | 3.86 | -13.94 | 4.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | 4.55 | -0.17 | 3.75 | -0.09 | 6.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.46 | 3.71 | 7.63 | 3.95 | 8.47 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.75 | -5.92 | 2.35 | -1.28 | 3.06 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 32.17 | 33.3 | 36.43 | 15.86 | -12.72 | |||||
Total Assets, 5 Yr. CAGR % | 5.68 | 4.21 | 3.9 | 2.5 | 0.85 | |||||
Tangible Book Value, 5 Yr. CAGR % | -25.99 | -15.64 | -29.23 | -23.47 | -14.83 | |||||
Common Equity, 5 Yr. CAGR % | 3.57 | 3.45 | 2.16 | 1.33 | 1.22 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.54 | 11.83 | 1.85 | 8.14 | -2.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | -24.48 | -6.59 | -20.35 | -21.04 | -42.35 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.1 | 38.35 | 10.36 | 8.9 | 8.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 10.01 | 38.09 | 10.34 | 8.88 | 8.3 |
- Stock Market
- Equities
- HSTM Stock
- Financials HealthStream, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition